Cirrhosis, which is the 9th leading cause of death in the United States. It develops over a period of years to decades because chronic necro-inflammatory activity gradually transforms the normal architecture into nodules. This proposal is focused on the ductular reaction, which is important predictor of the development of cirrhosis and refers to the preferential growth of biliary epithelial cells over hepatocytes, recognized at the interface zone of diseased livers. By either favoring biliary epithelial cell or inhibiting hepatocyte proliferation some cytokines and growth factors hasten the development of cirrhosis, whereas others that stimulate hepatocytes (IL-6/gp130, HGF) and inhibiting biliary epithelial cell proliferation prevent architectural distortion and liver failure. In this proposal we plan to: a. Characterize the effect of IL-6/gp130/STAT3 signaling, extracellular matrix and immunosuppressive drugs on biliary epithelial cell mitogenesis, apoptosis and maintenance of intercellular junctions, in vitro. b. Further characterize an experimental animal model of decompensated biliary cirrhosis in IL-6-/- mice after bile duct ligation using gene chip expression array analysis. Determine the role of p21 in hepatocyte proliferation and apoptosis during the development of cirrhosis and whether administration or exogenous recombinant growth factors, or transient transfection of vectors containing growth factors can influence the ductular reaction. c. Determine in humans, whether cytokine polymorphisms influence the susceptibility or the rate of progression of various chronic inflammatory liver diseases. The ultimate goal is to understand molecular mechanisms of differential biliary epithelial cell and hepatocyte growth control in diseased livers, which will serve as a rational basis for therapeutic intervention with cytokines and growth factors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK049615-07
Application #
6640833
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Doo, Edward
Project Start
1996-03-01
Project End
2006-12-31
Budget Start
2003-03-01
Budget End
2003-12-31
Support Year
7
Fiscal Year
2003
Total Cost
$248,136
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Specht, Susan; Isse, Kumiko; Nozaki, Isao et al. (2013) SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis. Clin Exp Metastasis 30:877-90
Demetris, Anthony J; Specht, Susan; Nozaki, Isao et al. (2008) Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes. J Hepatol 48:276-88
Lim, Kyu; Han, Chang; Xu, Lihong et al. (2008) Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res 68:553-60
Lunz 3rd, John G; Specht, Susan M; Murase, Noriko et al. (2007) Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46:1946-59
Demetris, Anthony J; Kelly, Dympna M; Eghtesad, Bijan et al. (2006) Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 30:986-93
Demetris, A J; Fontes, Paulo; Lunz 3rd, John G et al. (2006) Wound healing in the biliary tree of liver allografts. Cell Transplant 15 Suppl 1:S57-65
Demetris, A-J; Lunz 3rd, John-G; Specht, Susan et al. (2006) Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 12:3512-22
Han, Chang; Demetris, A Jake; Stolz, Donna B et al. (2006) Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway. J Biol Chem 281:24831-46
Toyokawa, Hideyoshi; Nakao, Atsunori; Stolz, Donna B et al. (2006) 3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury. Lab Invest 86:72-82
Nozaki, Isao; Lunz 3rd, John G; Specht, Susan et al. (2005) Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest 85:109-23

Showing the most recent 10 out of 43 publications